Lim CH et al., 2006-08: Randomized prospective crossover trial in 30 patients comparing methylene-blue-directed biopsies with random four-quadrant biopsies for dysplasia in Barrett's oesophagus. Dysplasia was found in 17 of 18 patients by random biopsy but in only 9 of 18 by methylene-blue-directed biopsy, and the authors discourage its use in surveillance.
Our study showed MBDB to be significantly less sensitive in detecting dysplasia than RB in Barrett's esophagus.
Lim CH et al., 2006-08: Randomized prospective crossover trial in 30 patients comparing methylene-blue-directed biopsies with random four-quadrant biopsies for dysplasia in Barrett's oesophagus. Dysplasia was found in 17 of 18 patients by random biopsy but in only 9 of 18 by methylene-blue-directed biopsy, and the authors discourage its use in surveillance. Study type: randomized prospective crossover trial, single centre. N=30 completed (17 low-grade dysplasia, 3 high-grade dysplasia, 10 no dysplasia at baseline). Country: United Kingdom (Leeds). Dose/route: methylene blue spray at chromoendoscopy, directed biopsies from unstained or heterogeneously stained mucosa versus 4 random quadrant biopsies every 2 cm. Light: standard endoscopic white light. Comparator: random 4-quadrant biopsy protocol (the then-standard). Result: dysplasia identified in 17 of 18 patients by random biopsy versus 9 of 18 by MB-directed biopsy, McNemar p=0.02. Funder/conflicts: not stated in abstract. Directly contradicts the detection-benefit half of C2. Study type: randomized trial.
